Comparison 2. Adverse events and other outcomes.
Outcome or subgroup title | No. of studies |
No. of participants |
Statistical method | Effect size |
---|---|---|---|---|
1 Re-operation for bleeding | 11 | 778 | Risk Ratio (M-H, Random, 95% CI) | 0.69 [0.26, 1.83] |
2 Mortality | 12 | 1061 | Risk Ratio (M-H, Random, 95% CI) | 1.72 [0.68, 4.33] |
3 Myocardial infarction | 12 | 876 | Risk Ratio (M-H, Random, 95% CI) | 1.38 [0.77, 2.50] |
4 Stroke (CVA) | 5 | 360 | Risk Ratio (M-H, Random, 95% CI) | 2.40 [0.68, 8.43] |
5 Any thrombosis | 9 | 691 | Risk Ratio (M-H, Random, 95% CI) | 1.46 [0.64, 3.35] |
6 Hypotension - during DDAVP/ Placebo infusion requiring treatment (fluids and/or vasoactive drugs) |
5 | 183 | Risk Ratio (M-H, Random, 95% CI) | 2.81 [1.50, 5.27] |